Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Transcranial Direct Current Stimulation shows early promise to ameliorate depression, especially if combined with other therapies and dosage optimized

___

Tran­scra­nial Direct Cur­rent Stim­u­la­tion Promis­ing for Major Depres­sive Dis­or­der (Psy­chi­a­try Advi­sor):

Tran­scra­nial direct cur­rent stim­u­la­tion (tDCS) is an inves­tiga­tive modal­i­ty for major depres­sive dis­or­der (MDD) that has shown some promis­ing results. Though it has a while before it is approved by the US Food and Drug Admin­is­tra­tion, clin­i­cians and patients have been clam­or­ing for an effec­tive treat­ment for MDD that is not asso­ci­at­ed with harm­ful adverse effects. Read the rest of this entry »

Pear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health

___

Pear Ther­a­peu­tics rakes in $50M to devel­op addi­tion­al dig­i­tal ther­a­peu­tics (Mobi­Health­News):

Boston- and San Fran­cis­co-based Pear Ther­a­peu­tics, mak­er of a pre­scrip­tion dig­i­tal ther­a­peu­tic plat­form, announced today the clo­sure of $50 mil­lion in Series B fund­ing. The round was led by Sin­ga­pore-based invest­ment com­pa­ny Temasek, with par­tic­i­pa­tion from return­ing investors 5AM Ven­tures, Arbore­tum Ven­tures, and JAZZ Ven­ture Part­ners, as well as new part­ners Novar­tis, EDBI, and the Bridge Builder’s Col­lab­o­ra­tive Read the rest of this entry »

Study: Rates of ADHD diagnosis and medication treatment continue to increase substantially

Begin­ning in about 1990, sub­stan­tial increas­es in the rates of ADHD diag­no­sis and med­ical treat­ment were found in sev­er­al nation­al­ly rep­re­sen­ta­tive sam­ples of US physi­cian office vis­its. For exam­ple, between 1995–96 and 2007-08, the num­ber of office vis­its at which an ADHD diag­no­sis was made increased by over 400% in adults — from 3.1 per 1000 vis­its to 14.5 per 1000 vis­its. And, the per­cent of adult office vis­its includ­ing both ADHD diag­no­sis and med­ica­tion increased from 1.9 to 11.4 per 1000 vis­its.

Among chil­dren aged 5 to 18, between 1991–92 and 2008-09, rates of ADHD diag­no­sis increased near­ly 4-fold among boys — from 39.5 to 144.6 per 1000 — and near­ly 6-fold for girls — from 12.3 and 68.5 per 1000 vis­its. Dur­ing this time, the rate of vis­its that also involved med­ica­tion treat­ment increased by sim­i­lar rates. Read the rest of this entry »

On the limits of Citicoline and the need for comprehensive brain injury rehabilitation

Citi­co­l­ine does not improve func­tion­al, cog­ni­tive sta­tus in patients with trau­mat­ic brain injury (Out­come Mag­a­zine):

Although approved for use for treat­ing trau­mat­ic brain injury (TBI) in near­ly 60 coun­tries, use of citi­co­l­ine in a ran­dom­ized tri­al that includ­ed more than 1,200 par­tic­i­pants with TBI did not result in improve­ment in func­tion­al and cog­ni­tive sta­tus, accord­ing to a study appear­ing in the Novem­ber 21 issue of JAMA.

Despite con­sid­er­able advances in emer­gency and crit­i­cal care man­age­ment of TBI as well as decades of research on poten­tial agents for neu­ro­pro­tec­tion or enhanced recov­ery, no effec­tive phar­ma­cother­a­py has yet been iden­ti­fied Read the rest of this entry »

Research: Cognitive Behaviour Therapy Helps Adults with ADHD

Many adults with ADHD do not obtain their diag­no­sis until adult­hood and have strug­gled with dif­fi­cul­ties relat­ed to undi­ag­nosed ADHD for their entire lives. As doc­u­ment­ed in recent stud­ies, this includes ele­vat­ed rates of depres­sion, anx­i­ety dis­or­ders, sub­stance use, work dif­fi­cul­ties and inter­per­son­al prob­lems.

As with chil­dren and ado­les­cents, med­ica­tion treat­ment for adults with ADHD can be quite help­ful, espe­cial­ly for reduc­ing core ADHD symp­toms of inat­ten­tion and hyperactivity/impulsivity.  How­ev­er, Read the rest of this entry »

Watch All Recordings Now (40+ Speakers, 12+ Hours)

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.